163 related articles for article (PubMed ID: 10869371)
1. A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT(2A) serotonin receptor but does not participate in activation via a "salt-bridge disruption" mechanism.
Kristiansen K; Kroeze WK; Willins DL; Gelber EI; Savage JE; Glennon RA; Roth BL
J Pharmacol Exp Ther; 2000 Jun; 293(3):735-46. PubMed ID: 10869371
[TBL] [Abstract][Full Text] [Related]
2. Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists.
Braden MR; Parrish JC; Naylor JC; Nichols DE
Mol Pharmacol; 2006 Dec; 70(6):1956-64. PubMed ID: 17000863
[TBL] [Abstract][Full Text] [Related]
3. Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs.
Egan CT; Herrick-Davis K; Teitler M
J Pharmacol Exp Ther; 1998 Jul; 286(1):85-90. PubMed ID: 9655845
[TBL] [Abstract][Full Text] [Related]
4. Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptors.
Egan C; Grinde E; Dupre A; Roth BL; Hake M; Teitler M; Herrick-Davis K
Synapse; 2000 Feb; 35(2):144-50. PubMed ID: 10611640
[TBL] [Abstract][Full Text] [Related]
5. Differential modes of agonist binding to 5-hydroxytryptamine(2A) serotonin receptors revealed by mutation and molecular modeling of conserved residues in transmembrane region 5.
Shapiro DA; Kristiansen K; Kroeze WK; Roth BL
Mol Pharmacol; 2000 Nov; 58(5):877-86. PubMed ID: 11040033
[TBL] [Abstract][Full Text] [Related]
6. Identification of two serine residues essential for agonist-induced 5-HT2A receptor desensitization.
Gray JA; Compton-Toth BA; Roth BL
Biochemistry; 2003 Sep; 42(36):10853-62. PubMed ID: 12962510
[TBL] [Abstract][Full Text] [Related]
7. Influence of a lysine 331 counterion on the pK(a) of aspartic acid 125: evidence for a salt-bridge interaction and role in alpha(1b)-adrenergic receptor activation.
Porter JE; Perez DM
J Pharmacol Exp Ther; 2000 Jan; 292(1):440-8. PubMed ID: 10604981
[TBL] [Abstract][Full Text] [Related]
8. Mutagenesis analysis of the serotonin 5-HT2C receptor and a Caenorhabditis elegans 5-HT2 homologue: conserved residues of helix 4 and helix 7 contribute to agonist-dependent activation of 5-HT2 receptors.
Xie J; Dernovici S; Ribeiro P
J Neurochem; 2005 Jan; 92(2):375-87. PubMed ID: 15663485
[TBL] [Abstract][Full Text] [Related]
9. Creation, expression, and characterization of a constitutively active mutant of the human serotonin 5-HT6 receptor.
Purohit A; Herrick-Davis K; Teitler M
Synapse; 2003 Mar; 47(3):218-24. PubMed ID: 12494404
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the highly conserved arginine within the Glu/Asp-Arg-Tyr motif of the alpha(1b)-adrenergic receptor: effects on receptor isomerization and activation.
Scheer A; Costa T; Fanelli F; De Benedetti PG; Mhaouty-Kodja S; Abuin L; Nenniger-Tosato M; Cotecchia S
Mol Pharmacol; 2000 Feb; 57(2):219-31. PubMed ID: 10648631
[TBL] [Abstract][Full Text] [Related]
11. Molecular modeling and docking studies of human 5-hydroxytryptamine 2A (5-HT2A) receptor for the identification of hotspots for ligand binding.
Kanagarajadurai K; Malini M; Bhattacharya A; Panicker MM; Sowdhamini R
Mol Biosyst; 2009 Dec; 5(12):1877-88. PubMed ID: 19763327
[TBL] [Abstract][Full Text] [Related]
12. Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.
Nachtergael I; Gaspard N; Langlet C; Robberecht P; Langer I
Cell Signal; 2006 Dec; 18(12):2121-30. PubMed ID: 16650965
[TBL] [Abstract][Full Text] [Related]
13. High constitutive activity of a virus-encoded seven transmembrane receptor in the absence of the conserved DRY motif (Asp-Arg-Tyr) in transmembrane helix 3.
Rosenkilde MM; Kledal TN; Schwartz TW
Mol Pharmacol; 2005 Jul; 68(1):11-9. PubMed ID: 15788740
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the roles of serines 5.43(239) and 5.46(242) for binding and potency of agonist ligands at the human serotonin 5-HT2A receptor.
Braden MR; Nichols DE
Mol Pharmacol; 2007 Nov; 72(5):1200-9. PubMed ID: 17715398
[TBL] [Abstract][Full Text] [Related]
15. Differential phospholipase C activation by phenylalkylamine serotonin 5-HT 2A receptor agonists.
Parrish JC; Braden MR; Gundy E; Nichols DE
J Neurochem; 2005 Dec; 95(6):1575-84. PubMed ID: 16277614
[TBL] [Abstract][Full Text] [Related]
16. Internalization and recycling of 5-HT2A receptors activated by serotonin and protein kinase C-mediated mechanisms.
Bhattacharyya S; Puri S; Miledi R; Panicker MM
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14470-5. PubMed ID: 12388782
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological characterization of a series of geometrically constrained 5-HT(2A/2C) receptor ligands.
Chambers JJ; Parrish JC; Jensen NH; Kurrasch-Orbaugh DM; Marona-Lewicka D; Nichols DE
J Med Chem; 2003 Jul; 46(16):3526-35. PubMed ID: 12877591
[TBL] [Abstract][Full Text] [Related]
18. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.
Wang CD; Gallaher TK; Shih JC
Mol Pharmacol; 1993 Jun; 43(6):931-40. PubMed ID: 8316224
[TBL] [Abstract][Full Text] [Related]
19. Mutant 5-hydroxytryptamine 1A receptor D116A is a receptor activated solely by synthetic ligands with a rich pharmacology.
Cussac D; Palmier C; Finana F; De Vries L; Tardif S; Léger C; Bernois S; Heusler P
J Pharmacol Exp Ther; 2009 Oct; 331(1):222-33. PubMed ID: 19605522
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat.
Watts SW; Thompson JM
J Pharmacol Exp Ther; 2004 Apr; 309(1):165-72. PubMed ID: 14724222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
